Comments on: India rejects patents for Pfizer’s Caduet, GSK’s rosiglitazone salt http://www.dancewithshadows.com/pillscribe/india-rejects-patents-for-pfizers-caduet-gsks-rosiglitazone-salt/ The best of pharma news and views Wed, 28 Jul 2010 09:17:36 +0000 hourly 1 http://wordpress.org/?v=3.1 By: India's revised Mashelkar committee report seeks to extend patents to incremental pharmaceutical inventions in Indian patent law | DWS Pill Scribe http://www.dancewithshadows.com/pillscribe/india-rejects-patents-for-pfizers-caduet-gsks-rosiglitazone-salt/comment-page-1/#comment-63 India's revised Mashelkar committee report seeks to extend patents to incremental pharmaceutical inventions in Indian patent law | DWS Pill Scribe Mon, 20 Apr 2009 16:47:15 +0000 http://www.dancewithshadows.com/pillscribe/?p=183#comment-63 [...] 1. Pfizer’s Applications Claiming Caduet (rejected pursuant to a PreGrant Opposition filed by Tor... [...] [...] 1. Pfizer’s Applications Claiming Caduet (rejected pursuant to a PreGrant Opposition filed by Tor… [...]

]]>